(Q35019924)

5 August 2017

1 reference

title

Update on human immunodeficiency virus (HIV)-2 infection (English)

1 reference

5 August 2017

author name string

Omobolaji T Campbell-Yesufu

series ordinal

1

1 reference

5 August 2017

Rajesh T Gandhi

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Clinical Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

780-787

1 reference

Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Antiretroviral drug resistance in human immunodeficiency virus type 2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

HIV-2: the forgotten AIDS virus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Non-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

A rapid review of rapid HIV antibody tests

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

In vitro correlates of HIV-2-mediated HIV-1 protection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Slower heterosexual spread of HIV-2 than HIV-1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Natural protection against HIV-1 infection provided by HIV-2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

AIDS due to HIV-2 infection--New Jersey.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2.

8 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

HIV type 2 in New York City, 2000-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Direct relationship between virus load and systemic immune activation in HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Lack of protection against HIV-1 infection among women with HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Progressive multifocal leukoencephalopathy in HIV-2-infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Multiple cranial neuropathy and HIV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

HIV type 2 demyelinating encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Quantitative detection of plasma human immunodeficiency virus type 2 subtype A RNA by the Nuclisens EasyQ Assay (version 1.1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Possible protective effect of HIV-2 against incident HIV-1 infection: review of available epidemiological and in vitro data

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau

25 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ248

Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3106263

Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients

9 December 2018

1 reference

12 December 2020

Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection

1 reference

12 December 2020

Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2

1 reference

12 December 2020

HIV-2 infection and HIV-associated nephropathy

1 reference

12 December 2020

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIQ248

1 reference

5 August 2017

1 reference

5 August 2017

1 reference